Vanderbilt School Of Medicine Basic Sciences

Ege Kavalali, chair of the Department of Pharmacology at Vanderbilt University School of Medicine Basic Sciences, wants to know how the billions of cells in our brains talk to each other all day. Read More

Thinking of getting an advanced degree? Graduate, professional students give their best advice. Read More

Hear from Class of 2025 graduate and cancer biologist Logan Northcutt on his dream to inspire young scientists. Read More

The lab of Hassane Mchaourab, director of the Center for Applied Artificial Intelligence in Protein Dynamics and professor of molecular physiology and biophysics, has developed a methodological blueprint that couples experimental double electron–electron resonance spectroscopy with an AI approach to help describe the conformational landscapes of a diverse spectrum of cell membrane transporters. Read More

John Jumper, BS’07, is a senior staff research scientist for DeepMind, a London-based company that made a huge leap forward in solving the protein folding problem using artificial intelligence. Jumper's work is so significant that he was awarded the 2023 Albert Lasker Award for Basic Medical Research. Read More

The Vanderbilt Memory and Alzheimer's Center hosted its fifth Annual Vanderbilt Alzheimer’s Disease Research Day on April 10 with the theme of “big data.” Aside from presentations from faculty from across campus and the School of Medicine Basic Sciences, the day featured data blitzes, a keynote presentation, and a poster reception with more than 45 posters. Read More

Vanderbilt University Professor of Biochemistry and Vice Dean of Basic Sciences Chuck Sanders and Professor of Biochemistry Bruce Carter have been hard at work searching for therapies, if not a cure, for CMT. Read More

Manuel Ascano, associate professor of biochemistry and pathology, microbiology and immunology, and Dr. Alissa Weaver, Cornelius Vanderbilt Chair and director of the Vanderbilt Center for Extracellular Vesicle Research, are one of nine U.S. research teams awarded funding from the National Science Foundation to more fully understand the potential biotechnological uses of RNA, ranging from crop disease protection to treatments that combat cancer. Read More